Top Analyst Upgrades and Downgrades (ALXN, ACAS, ATHN, BCSI, CERN, SCHW, CL, FMCN, NVDA, PG, RVBD)

Print Email

These are this Thursday morning’s top analyst upgrades, downgrades and initiations seen from Wall Street research calls:

Alexion Pharmaceuticals (NASDAQ: ALXN) Raised to Outperform at Oppenheimer.
American Capital, Ltd. (NASDAQ: ACAS) Cut to Sell at Stifel Nicolaus.
Athenahealth, Inc. (NASDAQ: ATHN) Raised to Buy at Auriga.
Blue Coat Systems (NASDAQ: BCSI) Raised to Outperform at FBR.
Cerner Corp. (NASDAQ: CERN) Started as Market Perform at Avondale.
Charles Schwab Corp. (NASDAQ: SCHW) Raised to Outperform at FBR.
Colgate-Palmolive (NYSE: CL) Started as Hold at Stifel Nicolaus.
Focus Media Holding Ltd. (NASDAQ: FMCN) Started as Overweight at JPMorgan.
NVIDIA Corp. (NASDAQ: NVDA) Cut to Hold at Roth.
Procter & Gamble (NYSE: PG) Started as Buy at Stifel Nicolaus.
Riverbed Technology, Inc. (NASDAQ: RVBD) Raised to Outperform at FBR.

You can join our free daily email distribution list to hear more about dividend trends, analyst upgrades and downgrades, top day trader and active trader alerts, news on Buffett and other investment gurus, IPOs, secondary offerings, private equity, and more.

JON C. OGG

Sponsor: 3 Recovery Stocks to Own Now – Get the names of the best cheap stocks to rebuild your wealth in 2010 and beyond.